After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Public engagement is often found at the heart of universities’ mission statements and is key to their institutional identities, but it is rarely central in their promotion and tenure processes. Indeed ...

NEW YORK--(BUSINESS WIRE)--JetBlue (Nasdaq: JBLU) today announced the expansion of its industry-leading Gateway programs with the launch of Gateway University - Tech Ops, a new pathway designed to ...

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...

Late on Wednesday, U.S. Food and Drug Administration (FDA) Commissioner Marty Makary and Center for Biologics Evaluation & Research (CBER) Director Vinay Prasad published an article in the New England ...

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments ...

FDA proposes using a well-supported mechanistic rationale plus natural history comparators to generate substantial evidence when randomized trials are infeasible for ultra-rare populations.

The announcement of a new immigration program, known as the million-dollar golden visa, has stirred curiosity and concern among those closely following U.S. immigration policies. Introduced by the ...

The U.S. Army is turning artificial intelligence from a niche experiment into a core part of how it fights, plans, and sustains itself. By creating a dedicated AI and machine learning officer track, ...

JetBlue strengthens its talent pipeline in the Northeast with initial partnerships at New York’s Vaughn College and Cape Cod Community College in Massachusetts JetBlue (Nasdaq: JBLU) today announced ...